Xconomy: Agenda: Bay Area Life Science Disruptors

Agenda: Bay Area Life Science Disruptors


	12.10.2015	AGENDA
		.
	1:00 – 2:00	Registration & Networking
	2:00 – 2:10	Welcome & Opening Remarks Jim Edwards, Publisher, Xconomy Aarif Khakoo, VP Research and San Francisco Site Head, Amgen
	2:10 – 2:30	Gene Editing: A Pioneer’s View of Its Promises and Perils Edward Lanphier, President and CEO, Sangamo BioSciences
	2:30 – 3:00	A CRISPR Business: The Caribou-Intellia Story Andy May, Chief Scientific Officer, Caribou Biosciences and Cofounder, Intellia Therapeutics Tom Barnes, Chief Scientific Officer, Intellia Therapeutics Jenny Rooke, Managing Director, 5 Prime Ventures
	3:00 – 3:30	Microbiome Pioneers: Who Can Stomach A Startup? Colleen Cutcliffe, CEO, Whole Biome Peter DiLaura, CEO, Second Genome
	3:30 – 4:00	Networking Break
	4:00 – 4:15	Big Data One: Making California Healthier Atul Butte, Director, Institute of Computational Health Sciences, UCSF
	4:15 – 4:30	Big Data Two: Helix and the Consumer Genome Justin Kao, SVP of Corporate Development, Operations, and Strategy, Helix
	4:30 – 4:45	Big Data Three: Gene Testing For Everyone Randy Scott, CEO, Invitae
	4:45 – 5:15	You Will Be Sequenced. Who Will Benefit? Atul Butte, Director, Institute of Computational Health Sciences, UCSF Randy Scott, CEO, Invitae Justin Kao, SVP of Corporate Development, Operations, and Strategy, Helix Nina Kjellson, General Partner, Canaan Partners (Moderator)
	5:15 – 5:45	Finding The Ethical Line In 21st Century Biology Hank Greely, Director, Center for Law and the Biosciences, Stanford University Marcy Darnovsky, Director, Center for Genetics and Society
	5:45 – 6:45	Networking Reception